Biologics

Spine biologics market to grow at CAGR of 4.09% through 2022

The global spine biologics market is expected to grow at a compound annual growth rate of 4.09 percent from 2018 to 2022, according to a 360 Market Updates report.

By: Staff

Monday, June 11th, 2018

Key vendors in the spine biologics market include:

1. Alphatec Spine

2. Globus Medical

3. Medtronic

4. NuVasive

5. AlloSource

6. Amendia

7. ChoiceSpine

8. DePuy Synthes

9. Exactech

10. Harvest Technologies

More articles on biologics:

3 things to know about Lattice Biologics

8 key surgeon Q&As on biologics in orthopedics & spine

International Stem Cell Corp. to launch joint supplement for osteoarthritis pain in Q3 2018

Next Up in Biologics

Cerapedics' lumbar spine bone graft used in 1st US patient

Sharad Rajpal, MD, performed the first U.S. case using Cerapedics’ PearlMatrix P-15 bone graft for lumbar spinal fusion since its…

By: Carly Behm
Yesterday
Bone Biologics files patent for regenerative spine protein

Bone Biologics filed a patent application with the U.S. Patent and Trademark Office for its NELL-1 protein, according to a…

By: Carly Behm
Friday, June 27th, 2025
6 spine, orthopedic biologics updates

From new FDA nods to debuts, here are six key developments in spine and orthopedic biologics. 1. Physicians at Huntington…

By: Carly Behm
Thursday, June 26th, 2025

Comments are closed.

Transforming patient engagement with AI-powered communications

Next Up in Biologics

Cerapedics' lumbar spine bone graft used in 1st US patient

Bone Biologics files patent for regenerative spine protein

6 spine, orthopedic biologics updates

Stay Informed with Becker's Spine Review Newsletter